We are live on ! Find out more
IDYA icon

IDEAYA Biosciences
IDYA

29 hedge funds and large institutions have $83.6M invested in IDEAYA Biosciences in 2019 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

71% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 7

69% more capital invested

Capital invested by funds: $49.5M → $83.6M (+$34.2M)

27.41% more ownership

Funds ownership: 27.44% → 54.85% (+27%)

21% more funds holding

Funds holding: 24 → 29 (+5)

50% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 6

Holders
29
Holders Change
+5
Holders Change %
+20.83%
% of All Funds
0.57%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.04%
New
12
Increased
3
Reduced
6
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BCM
Bridgeway Capital Management
Texas
+$250K
2
OGC
One68 Global Capital
New York
+$199K
3
6CM
683 Capital Management
New York
+$160K
4
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$144K
5
AIM
Alambic Investment Management
California
+$141K

Top Sellers

1
DM
Deerfield Management
New York
-$3.81M
2
Victory Capital Management
Victory Capital Management
Texas
-$1.32M
3
Goldman Sachs
Goldman Sachs
New York
-$306K
4
Millennium Management
Millennium Management
New York
-$167K
5
LCM
Laurion Capital Management
New York
-$156K
Name Holding Trade Value Shares
Change 		Change in
Stake
5VM
1
5AM Venture Management
California
$26M +$24.7M +3,463,066 New
CPX
2
Canaan Partners X
California
$20M +$19M +2,660,713 New
BI
3
BVF Inc
California
$10.8M -$35.7K -5,000 -0.3%
PA
4
Perceptive Advisors
New York
$8.56M – – –
BC
5
Boxer Capital
California
$5.73M – – –
AI
6
Alphabet Inc
California
$5.65M – – –
BBA
7
Baker Bros. Advisors
New York
$1.5M – – –
Point72 Asset Management
8
Point72 Asset Management
Connecticut
$1.48M – – –
DCM
9
Driehaus Capital Management
Illinois
$1.31M – – –
BCM
10
Bridgeway Capital Management
Texas
$638K +$250K +35,000 +70%
Vanguard Group
11
Vanguard Group
Pennsylvania
$582K -$7.51K -1,053 -1%
Millennium Management
12
Millennium Management
New York
$290K -$167K -23,356 -38%
OGC
13
One68 Global Capital
New York
$209K +$199K +27,914 New
6CM
14
683 Capital Management
New York
$168K +$160K +22,364 New
Jacobs Levy Equity Management
15
Jacobs Levy Equity Management
New Jersey
$151K +$144K +20,118 New
Goldman Sachs
16
Goldman Sachs
New York
$149K -$306K -42,841 -68%
AIM
17
Alambic Investment Management
California
$148K +$141K +19,753 New
Squarepoint
18
Squarepoint
New York
$143K +$42.5K +5,954 +45%
Susquehanna International Group
19
Susquehanna International Group
Pennsylvania
$96K +$90.9K +12,738 New
BlackRock
20
BlackRock
New York
$86K -$29.8K -4,173 -27%
PCM
21
Prelude Capital Management
New York
$13K +$11.9K +1,674 New
CSS
22
Cubist Systematic Strategies
Connecticut
$10K +$7.47K +1,047 +326%
Morgan Stanley
23
Morgan Stanley
New York
$7K +$6.42K +900 New
LTFS
24
Ladenburg Thalmann Financial Services
Florida
$6K +$6.06K +850 New
WEC
25
Winslow Evans & Crocker
Massachusetts
$4K – – –
1
2

IDYA Hedge Fund Activity: Q4 2019 in Review

29 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in IDEAYA Biosciences (IDYA) for Q4 2019, worth a combined $83.6M — up 69% from $49.5M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new IDYA positions and 7 closed out — a net gain of 5 holders — while 3 added to existing stakes and 6 trimmed.

The largest buyer was Bridgeway Capital Management, adding an estimated $250K. The largest seller was Deerfield Management, exiting entirely with an estimated $3.81M sold.

  • 29 institutional investors held IDEAYA Biosciences (IDYA) as of Q4 2019, up from 24 in Q3 2019.
  • Funds reported $83.6M of IDEAYA Biosciences stock for Q4 2019, up 69% quarter-over-quarter.
  • 12 funds opened new IDEAYA Biosciences positions in Q4 2019 and 7 closed out, a net change of +5 holders.
  • The largest IDEAYA Biosciences buyer in Q4 2019 was Bridgeway Capital Management, an estimated $250K added.
  • The largest IDEAYA Biosciences seller in Q4 2019 was Deerfield Management, an estimated $3.81M sold.

Based on aggregated 13F filings for Q4 2019.